DNAG — DNAPrint Genomics Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $5.41m
- $2.43m
Annual cashflow statement for DNAPrint Genomics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2002 December 31st | C2003 December 31st | 2004 December 31st | 2005 December 31st | 2006 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10KSB | 10KSB | 10KSB | 10KSB | 10KSB |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -3.11 | -7.79 | -3.73 | -8.72 | -12.3 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 0.957 | 6.05 | 0.896 | 4.3 | 3.68 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.405 | 0.509 | -1.11 | 0.585 | 2.35 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Cash from Operating Activities | -1.57 | -1.11 | -3.76 | -3.61 | -5.78 |
| Capital Expenditures | -0.016 | -0.014 | -0.057 | -0.124 | -0.391 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.01 | 0 | -0.194 | -2.07 | 0.555 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.006 | -0.014 | -0.251 | -2.2 | 0.164 |
| Financing Cash Flow Items | 0.085 | 0.238 | 0 | 0 | 0 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 1.55 | 1.38 | 4.73 | 6.63 | 4.41 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.031 | 0.254 | 0.713 | 0.828 | -1.21 |